Adverse Event

Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement

Post author:GHIAA Admin
Post published:January 3, 2022
Post category:

The development of the MAPGuide^Ⓡ platform and Equitable Access Toolkit was supported by the Wellcome Trust (grant numbers 219632/Z/19/Z, 221648/Z/20/Z and 225262/Z/22/Z).

If you are interested in providing funding or an in-kind contribution to support GHIAA’s continuing equitable access advocacy work and resource development activities, please contact us using the form below.

Global Healthcare Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.